BLEOMYCIN SULFATE 15 UNIT VIAL

Strength

15 [USP'U]/1

Manufacturer

NDC

00409033220

Classification

Generic

Dosage Form

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Route

INTRAMUSCULAR; INTRAPLEURAL; INTRAVENOUS; SUBCUTANEOUS

Last Updated

4/22/2026

Active Ingredients

Approval Type

Generic (ANDA)

FDA Application

On Market Since

4/25/2015